First human gets new antibody aimed at rabies virus
Wednesday, September 30, 2009 - 13:21
in Health & Medicine
MassBiologics of the University of Massachusetts Medical School today announced the beginning of a Phase 1 clinical trial, testing the safety and activity of a human monoclonal antibody (MAB) developed to neutralize the rabies virus.